急性間欠性ポルフィリン症の世界市場 2021年:メーカー別、地域別、種類・用途別

【英語タイトル】Global Acute Intermittent Porphyria Market 2021 by Company, Regions, Type and Application, Forecast to 2026

GlobalInfoResearchが出版した調査資料(GIR21AR00327)・商品コード:GIR21AR00327
・発行会社(調査会社):GlobalInfoResearch
・発行日:2021年4月(※2024年版があります。お問い合わせください)
・ページ数:105
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後2~3日)
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
GlobalInfoResearch社の本調査レポートでは、急性間欠性ポルフィリン症の世界市場を広く調査・分析し、今後の市場展望をまとめております。急性間欠性ポルフィリン症の種類別市場規模(ゴナドトロピン放出ホルモン類似体、予防的ヘマチン注入)、用途別市場規模(病院&診療所、研究センター)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(企業概要、製品概要、販売量、価格、売上):Valeo、Continental、Magna International、Hitachi Automotive、Fujitsu、Ficosa
・メーカー別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:ゴナドトロピン放出ホルモン類似体、予防的ヘマチン注入
・用途別分析2016年-2026年:病院&診療所、研究センター
・急性間欠性ポルフィリン症の北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・急性間欠性ポルフィリン症のヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・急性間欠性ポルフィリン症のアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・急性間欠性ポルフィリン症の南米市場規模2016年-2026年:ブラジル、アルゼンチン
・急性間欠性ポルフィリン症の中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
【レポートの概要】

The Acute Intermittent Porphyria market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Acute Intermittent Porphyria size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global Acute Intermittent Porphyria market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Acute Intermittent Porphyria market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Gonadotropin-Releasing Hormone Analogues
Prophylactic Hematin Infusions

Market segment by Application, can be divided into
Hospitals & Clinics
Research Centers

Market segment by players, this report covers
Dahaner
Roche
Bio-Rad Laboratories
Siemens
ARKRAY
Sysmex Corporation
ACON Laboratories

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

【レポートの目次】

1 Market Overview
1.1 Product Overview and Scope of Acute Intermittent Porphyria
1.2 Classification of Acute Intermittent Porphyria by Type
1.2.1 Overview: Global Acute Intermittent Porphyria Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Acute Intermittent Porphyria Revenue Market Share by Type in 2020
1.2.3 Gonadotropin-Releasing Hormone Analogues
1.2.4 Prophylactic Hematin Infusions
1.3 Global Acute Intermittent Porphyria Market by Application
1.3.1 Overview: Global Acute Intermittent Porphyria Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals & Clinics
1.3.3 Research Centers
1.4 Global Acute Intermittent Porphyria Market Size & Forecast
1.5 Global Acute Intermittent Porphyria Market Size and Forecast by Region
1.5.1 Global Acute Intermittent Porphyria Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Acute Intermittent Porphyria Market Size by Region, (2016-2021)
1.5.3 North America Acute Intermittent Porphyria Market Size and Prospect (2016-2026)
1.5.4 Europe Acute Intermittent Porphyria Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Acute Intermittent Porphyria Market Size and Prospect (2016-2026)
1.5.6 South America Acute Intermittent Porphyria Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Acute Intermittent Porphyria Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Acute Intermittent Porphyria Market Drivers
1.6.2 Acute Intermittent Porphyria Market Restraints
1.6.3 Acute Intermittent Porphyria Trends Analysis
2 Company Profiles
2.1 Dahaner
2.1.1 Dahaner Details
2.1.2 Dahaner Major Business
2.1.3 Dahaner Acute Intermittent Porphyria Product and Solutions
2.1.4 Dahaner Acute Intermittent Porphyria Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Dahaner Recent Developments and Future Plans
2.2 Roche
2.2.1 Roche Details
2.2.2 Roche Major Business
2.2.3 Roche Acute Intermittent Porphyria Product and Solutions
2.2.4 Roche Acute Intermittent Porphyria Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Roche Recent Developments and Future Plans
2.3 Bio-Rad Laboratories
2.3.1 Bio-Rad Laboratories Details
2.3.2 Bio-Rad Laboratories Major Business
2.3.3 Bio-Rad Laboratories Acute Intermittent Porphyria Product and Solutions
2.3.4 Bio-Rad Laboratories Acute Intermittent Porphyria Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Bio-Rad Laboratories Recent Developments and Future Plans
2.4 Siemens
2.4.1 Siemens Details
2.4.2 Siemens Major Business
2.4.3 Siemens Acute Intermittent Porphyria Product and Solutions
2.4.4 Siemens Acute Intermittent Porphyria Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Siemens Recent Developments and Future Plans
2.5 ARKRAY
2.5.1 ARKRAY Details
2.5.2 ARKRAY Major Business
2.5.3 ARKRAY Acute Intermittent Porphyria Product and Solutions
2.5.4 ARKRAY Acute Intermittent Porphyria Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 ARKRAY Recent Developments and Future Plans
2.6 Sysmex Corporation
2.6.1 Sysmex Corporation Details
2.6.2 Sysmex Corporation Major Business
2.6.3 Sysmex Corporation Acute Intermittent Porphyria Product and Solutions
2.6.4 Sysmex Corporation Acute Intermittent Porphyria Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Sysmex Corporation Recent Developments and Future Plans
2.7 ACON Laboratories
2.7.1 ACON Laboratories Details
2.7.2 ACON Laboratories Major Business
2.7.3 ACON Laboratories Acute Intermittent Porphyria Product and Solutions
2.7.4 ACON Laboratories Acute Intermittent Porphyria Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 ACON Laboratories Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Acute Intermittent Porphyria Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Acute Intermittent Porphyria Players Market Share
3.2.2 Top 10 Acute Intermittent Porphyria Players Market Share
3.2.3 Market Competition Trend
3.3 Acute Intermittent Porphyria Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Acute Intermittent Porphyria Revenue and Market Share by Type (2016-2021)
4.2 Global Acute Intermittent Porphyria Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Acute Intermittent Porphyria Revenue Market Share by Application (2016-2021)
5.2 Acute Intermittent Porphyria Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Acute Intermittent Porphyria Revenue by Type (2016-2026)
6.2 North America Acute Intermittent Porphyria Revenue by Application (2016-2026)
6.3 North America Acute Intermittent Porphyria Market Size by Country
6.3.1 North America Acute Intermittent Porphyria Revenue by Country (2016-2026)
6.3.2 United States Acute Intermittent Porphyria Market Size and Forecast (2016-2026)
6.3.3 Canada Acute Intermittent Porphyria Market Size and Forecast (2016-2026)
6.3.4 Mexico Acute Intermittent Porphyria Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Acute Intermittent Porphyria Revenue by Type (2016-2026)
7.2 Europe Acute Intermittent Porphyria Revenue by Application (2016-2026)
7.3 Europe Acute Intermittent Porphyria Market Size by Country
7.3.1 Europe Acute Intermittent Porphyria Revenue by Country (2016-2026)
7.3.2 Germany Acute Intermittent Porphyria Market Size and Forecast (2016-2026)
7.3.3 France Acute Intermittent Porphyria Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Acute Intermittent Porphyria Market Size and Forecast (2016-2026)
7.3.5 Russia Acute Intermittent Porphyria Market Size and Forecast (2016-2026)
7.3.6 Italy Acute Intermittent Porphyria Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Acute Intermittent Porphyria Revenue by Type (2016-2026)
8.2 Asia-Pacific Acute Intermittent Porphyria Revenue by Application (2016-2026)
8.3 Asia-Pacific Acute Intermittent Porphyria Market Size by Region
8.3.1 Asia-Pacific Acute Intermittent Porphyria Revenue by Region (2016-2026)
8.3.2 China Acute Intermittent Porphyria Market Size and Forecast (2016-2026)
8.3.3 Japan Acute Intermittent Porphyria Market Size and Forecast (2016-2026)
8.3.4 South Korea Acute Intermittent Porphyria Market Size and Forecast (2016-2026)
8.3.5 India Acute Intermittent Porphyria Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Acute Intermittent Porphyria Market Size and Forecast (2016-2026)
8.3.7 Australia Acute Intermittent Porphyria Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Acute Intermittent Porphyria Revenue by Type (2016-2026)
9.2 South America Acute Intermittent Porphyria Revenue by Application (2016-2026)
9.3 South America Acute Intermittent Porphyria Market Size by Country
9.3.1 South America Acute Intermittent Porphyria Revenue by Country (2016-2026)
9.3.2 Brazil Acute Intermittent Porphyria Market Size and Forecast (2016-2026)
9.3.3 Argentina Acute Intermittent Porphyria Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Acute Intermittent Porphyria Revenue by Type (2016-2026)
10.2 Middle East & Africa Acute Intermittent Porphyria Revenue by Application (2016-2026)
10.3 Middle East & Africa Acute Intermittent Porphyria Market Size by Country
10.3.1 Middle East & Africa Acute Intermittent Porphyria Revenue by Country (2016-2026)
10.3.2 Turkey Acute Intermittent Porphyria Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Acute Intermittent Porphyria Market Size and Forecast (2016-2026)
10.3.4 UAE Acute Intermittent Porphyria Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Acute Intermittent Porphyria Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Acute Intermittent Porphyria Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Acute Intermittent Porphyria Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Acute Intermittent Porphyria Revenue (USD Million) by Region (2016-2021)
Table 5. Global Acute Intermittent Porphyria Revenue Market Share by Region (2021-2026)
Table 6. Dahaner Corporate Information, Head Office, and Major Competitors
Table 7. Dahaner Major Business
Table 8. Dahaner Acute Intermittent Porphyria Product and Solutions
Table 9. Dahaner Acute Intermittent Porphyria Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Roche Corporate Information, Head Office, and Major Competitors
Table 11. Roche Major Business
Table 12. Roche Acute Intermittent Porphyria Product and Solutions
Table 13. Roche Acute Intermittent Porphyria Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Bio-Rad Laboratories Corporate Information, Head Office, and Major Competitors
Table 15. Bio-Rad Laboratories Major Business
Table 16. Bio-Rad Laboratories Acute Intermittent Porphyria Product and Solutions
Table 17. Bio-Rad Laboratories Acute Intermittent Porphyria Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Siemens Corporate Information, Head Office, and Major Competitors
Table 19. Siemens Major Business
Table 20. Siemens Acute Intermittent Porphyria Product and Solutions
Table 21. Siemens Acute Intermittent Porphyria Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. ARKRAY Corporate Information, Head Office, and Major Competitors
Table 23. ARKRAY Major Business
Table 24. ARKRAY Acute Intermittent Porphyria Product and Solutions
Table 25. ARKRAY Acute Intermittent Porphyria Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Sysmex Corporation Corporate Information, Head Office, and Major Competitors
Table 27. Sysmex Corporation Major Business
Table 28. Sysmex Corporation Acute Intermittent Porphyria Product and Solutions
Table 29. Sysmex Corporation Acute Intermittent Porphyria Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. ACON Laboratories Corporate Information, Head Office, and Major Competitors
Table 31. ACON Laboratories Major Business
Table 32. ACON Laboratories Acute Intermittent Porphyria Product and Solutions
Table 33. ACON Laboratories Acute Intermittent Porphyria Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Global Acute Intermittent Porphyria Revenue (USD Million) by Players (2019-2021)
Table 35. Global Acute Intermittent Porphyria Revenue Share by Players (2019-2021)
Table 36. Breakdown of Acute Intermittent Porphyria by Company Type (Tier 1, Tier 2 and Tier 3)
Table 37. Acute Intermittent Porphyria Players Head Office, Products and Services Provided
Table 38. Acute Intermittent Porphyria Mergers & Acquisitions in the Past Five Years
Table 39. Acute Intermittent Porphyria New Entrants and Expansion Plans
Table 40. Global Acute Intermittent Porphyria Revenue (USD Million) by Type (2016-2021)
Table 41. Global Acute Intermittent Porphyria Revenue Share by Type (2016-2021)
Table 42. Global Acute Intermittent Porphyria Revenue Forecast by Type (2021-2026)
Table 43. Global Acute Intermittent Porphyria Revenue by Application (2016-2021)
Table 44. Global Acute Intermittent Porphyria Revenue Forecast by Application (2021-2026)
Table 45. North America Acute Intermittent Porphyria Revenue by Type (2016-2021) & (USD Million)
Table 46. North America Acute Intermittent Porphyria Revenue by Type (2021-2026) & (USD Million)
Table 47. North America Acute Intermittent Porphyria Revenue by Application (2016-2021) & (USD Million)
Table 48. North America Acute Intermittent Porphyria Revenue by Application (2021-2026) & (USD Million)
Table 49. North America Acute Intermittent Porphyria Revenue by Country (2016-2021) & (USD Million)
Table 50. North America Acute Intermittent Porphyria Revenue by Country (2021-2026) & (USD Million)
Table 51. Europe Acute Intermittent Porphyria Revenue by Type (2016-2021) & (USD Million)
Table 52. Europe Acute Intermittent Porphyria Revenue by Type (2021-2026) & (USD Million)
Table 53. Europe Acute Intermittent Porphyria Revenue by Application (2016-2021) & (USD Million)
Table 54. Europe Acute Intermittent Porphyria Revenue by Application (2021-2026) & (USD Million)
Table 55. Europe Acute Intermittent Porphyria Revenue by Country (2016-2021) & (USD Million)
Table 56. Europe Acute Intermittent Porphyria Revenue by Country (2021-2026) & (USD Million)
Table 57. Asia-Pacific Acute Intermittent Porphyria Revenue by Type (2016-2021) & (USD Million)
Table 58. Asia-Pacific Acute Intermittent Porphyria Revenue by Type (2021-2026) & (USD Million)
Table 59. Asia-Pacific Acute Intermittent Porphyria Revenue by Application (2016-2021) & (USD Million)
Table 60. Asia-Pacific Acute Intermittent Porphyria Revenue by Application (2021-2026) & (USD Million)
Table 61. Asia-Pacific Acute Intermittent Porphyria Revenue by Region (2016-2021) & (USD Million)
Table 62. Asia-Pacific Acute Intermittent Porphyria Revenue by Region (2021-2026) & (USD Million)
Table 63. South America Acute Intermittent Porphyria Revenue by Type (2016-2021) & (USD Million)
Table 64. South America Acute Intermittent Porphyria Revenue by Type (2021-2026) & (USD Million)
Table 65. South America Acute Intermittent Porphyria Revenue by Application (2016-2021) & (USD Million)
Table 66. South America Acute Intermittent Porphyria Revenue by Application (2021-2026) & (USD Million)
Table 67. South America Acute Intermittent Porphyria Revenue by Country (2016-2021) & (USD Million)
Table 68. South America Acute Intermittent Porphyria Revenue by Country (2021-2026) & (USD Million)
Table 69. Middle East & Africa Acute Intermittent Porphyria Revenue by Type (2016-2021) & (USD Million)
Table 70. Middle East & Africa Acute Intermittent Porphyria Revenue by Type (2021-2026) & (USD Million)
Table 71. Middle East & Africa Acute Intermittent Porphyria Revenue by Application (2016-2021) & (USD Million)
Table 72. Middle East & Africa Acute Intermittent Porphyria Revenue by Application (2021-2026) & (USD Million)
Table 73. Middle East & Africa Acute Intermittent Porphyria Revenue by Country (2016-2021) & (USD Million)
Table 74. Middle East & Africa Acute Intermittent Porphyria Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Acute Intermittent Porphyria Picture
Figure 2. Global Acute Intermittent Porphyria Revenue Market Share by Type in 2020
Figure 3. Gonadotropin-Releasing Hormone Analogues
Figure 4. Prophylactic Hematin Infusions
Figure 5. Acute Intermittent Porphyria Revenue Market Share by Application in 2020
Figure 6. Hospitals & Clinics Picture
Figure 7. Research Centers Picture
Figure 8. Global Acute Intermittent Porphyria Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 9. Global Acute Intermittent Porphyria Revenue and Forecast (2016-2026) & (USD Million)
Figure 10. Global Acute Intermittent Porphyria Revenue Market Share by Region (2016-2026)
Figure 11. Global Acute Intermittent Porphyria Revenue Market Share by Region in 2020
Figure 12. North America Acute Intermittent Porphyria Revenue (USD Million) and Growth Rate (2016-2026)
Figure 13. Europe Acute Intermittent Porphyria Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Asia-Pacific Acute Intermittent Porphyria Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. South America Acute Intermittent Porphyria Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Acute Intermittent Porphyria Market Drivers
Figure 17. Acute Intermittent Porphyria Market Restraints
Figure 18. Acute Intermittent Porphyria Market Trends
Figure 19. Dahaner Recent Developments and Future Plans
Figure 20. Roche Recent Developments and Future Plans
Figure 21. Bio-Rad Laboratories Recent Developments and Future Plans
Figure 22. Siemens Recent Developments and Future Plans
Figure 23. ARKRAY Recent Developments and Future Plans
Figure 24. Sysmex Corporation Recent Developments and Future Plans
Figure 25. ACON Laboratories Recent Developments and Future Plans
Figure 27. Global Acute Intermittent Porphyria Revenue Share by Players in 2020
Figure 28. Acute Intermittent Porphyria Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 29. Global Top 3 Players Acute Intermittent Porphyria Revenue Market Share in 2020
Figure 30. Global Top 10 Players Acute Intermittent Porphyria Revenue Market Share in 2020
Figure 31. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 32. Global Acute Intermittent Porphyria Revenue Share by Type in 2020
Figure 33. Global Acute Intermittent Porphyria Market Share Forecast by Type (2021-2026)
Figure 34. Global Acute Intermittent Porphyria Revenue Share by Application in 2020
Figure 35. Global Acute Intermittent Porphyria Market Share Forecast by Application (2021-2026)
Figure 36. North America Acute Intermittent Porphyria Sales Market Share by Type (2016-2026)
Figure 37. North America Acute Intermittent Porphyria Sales Market Share by Application (2016-2026)
Figure 38. North America Acute Intermittent Porphyria Revenue Market Share by Country (2016-2026)
Figure 39. United States Acute Intermittent Porphyria Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 40. Canada Acute Intermittent Porphyria Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Mexico Acute Intermittent Porphyria Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Europe Acute Intermittent Porphyria Sales Market Share by Type (2016-2026)
Figure 43. Europe Acute Intermittent Porphyria Sales Market Share by Application (2016-2026)
Figure 44. Europe Acute Intermittent Porphyria Revenue Market Share by Country (2016-2026)
Figure 45. Germany Acute Intermittent Porphyria Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. France Acute Intermittent Porphyria Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. United Kingdom Acute Intermittent Porphyria Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Russia Acute Intermittent Porphyria Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Italy Acute Intermittent Porphyria Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Asia-Pacific Acute Intermittent Porphyria Sales Market Share by Type (2016-2026)
Figure 51. Asia-Pacific Acute Intermittent Porphyria Sales Market Share by Application (2016-2026)
Figure 52. Asia-Pacific Acute Intermittent Porphyria Revenue Market Share by Region (2016-2026)
Figure 53. China Acute Intermittent Porphyria Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Japan Acute Intermittent Porphyria Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. South Korea Acute Intermittent Porphyria Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. India Acute Intermittent Porphyria Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Southeast Asia Acute Intermittent Porphyria Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Australia Acute Intermittent Porphyria Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. South America Acute Intermittent Porphyria Sales Market Share by Type (2016-2026)
Figure 60. South America Acute Intermittent Porphyria Sales Market Share by Application (2016-2026)
Figure 61. South America Acute Intermittent Porphyria Revenue Market Share by Country (2016-2026)
Figure 62. Brazil Acute Intermittent Porphyria Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Argentina Acute Intermittent Porphyria Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Middle East and Africa Acute Intermittent Porphyria Sales Market Share by Type (2016-2026)
Figure 65. Middle East and Africa Acute Intermittent Porphyria Sales Market Share by Application (2016-2026)
Figure 66. Middle East and Africa Acute Intermittent Porphyria Revenue Market Share by Country (2016-2026)
Figure 67. Turkey Acute Intermittent Porphyria Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Saudi Arabia Acute Intermittent Porphyria Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. UAE Acute Intermittent Porphyria Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Methodology
Figure 71. Research Process and Data Source


【掲載企業】

Valeo、Continental、Magna International、Hitachi Automotive、Fujitsu、Ficosa

★調査レポート[急性間欠性ポルフィリン症の世界市場 2021年:メーカー別、地域別、種類・用途別] (コード:GIR21AR00327)販売に関する免責事項を必ずご確認ください。
★調査レポート[急性間欠性ポルフィリン症の世界市場 2021年:メーカー別、地域別、種類・用途別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆